CoreFirst Bank & Trust’s AbbVie ABBV Stock Holding History

CoreFirst Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$944K	Hold	3,751	–	–	0.47%	50
2026 Q1	$816K	Sell	3,751 -614	-14%	-$136K	0.43%	50
2025 Q4	$997K	Sell	4,365 -58	-1%	-$13.2K	0.54%	41
2025 Q3	$1.02M	Hold	4,423	–	–	0.55%	38
2025 Q2	$821K	Buy	4,423 +496	+13%	+$92.2K	0.46%	50
2025 Q1	$823K	Sell	3,927 -110	-3%	-$21.4K	0.53%	46
2024 Q4	$717K	Hold	4,037	–	–	0.43%	55
2024 Q3	$797K	Sell	4,037 -15	-0.4%	-$2.8K	0.46%	49
2024 Q2	$695K	Sell	4,052 -30	-0.7%	-$4.97K	0.47%	55
2024 Q1	$743K	Sell	4,082 -64	-2%	-$11K	0.46%	53
2023 Q4	$643K	Sell	4,146 -1,874	-31%	-$273K	0.43%	58
2023 Q3	$897K	Sell	6,020 -15	-0.2%	-$2.2K	0.64%	38
2023 Q2	$813K	Sell	6,035 -90	-1%	-$13.2K	0.57%	40
2023 Q1	$976K	Sell	6,125 -5	-0.1%	-$764	0.71%	34
2022 Q4	$991K	Sell	6,130 -17	-0.3%	-$2.61K	0.75%	31
2022 Q3	$825K	Buy	6,147 +59	+1%	+$8.47K	0.71%	32
2022 Q2	$932K	Sell	6,088 -120	-2%	-$18.3K	0.74%	31
2022 Q1	$1.01M	Buy	6,208 +202	+3%	+$29.3K	0.69%	36
2021 Q4	$813K	Sell	6,006 -250	-4%	-$29.5K	0.53%	47
2021 Q3	$675K	Sell	6,256 -549	-8%	-$62.7K	0.47%	52
2021 Q2	$767K	Hold	6,805	–	–	0.52%	45
2021 Q1	$736K	Hold	6,805	–	–	0.51%	48
2020 Q4	$729K	Buy	+6,805	New	+$654K	0.54%	42

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CoreFirst Bank & Trust's ABBV Position: Q2 2026 in Review

CoreFirst Bank & Trust held its AbbVie (ABBV) position steady in Q2 2026 at 3,751 shares worth $944K. The position accounts for 0.47% of the portfolio, ranked #50.

CoreFirst Bank & Trust first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.02M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

CoreFirst Bank & Trust held 3,751 shares of AbbVie worth $944K as of Q2 2026.
CoreFirst Bank & Trust left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.47% of CoreFirst Bank & Trust's portfolio in Q2 2026, its #50 holding.
CoreFirst Bank & Trust first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
CoreFirst Bank & Trust's AbbVie position peaked at $1.02M in Q3 2025.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2026, filed 5 Aug 2026.